The Open Respiratory Medicine Journal




ISSN: 1874-3064 ― Volume 13, 2019

Angiosarcoma Presenting with Spontaneous Hydropneumothorax: Report of a Case and Review of the Literature



Jung H Chang*, 1, Ji H Kim 1, So-Hyeon Hong 1, Myung E Song 1, Yon J Ryu 1, Jin H Lee 1, Sung S Shim 2, Min-Sun Cho 3, Yun S Sim 4
1 Division of Pulmonary and Critical Care Medicine, Department of Medicine
2 Department of Radiology
3 Pathology, School of Medicine, Ewha Womans University, Seoul, South Korea
4 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, South Korea

Abstract

Angiosarcoma is a rare malignant tumor of soft tissue. Because angiosarcoma originates from endothelial cells, it can occur in any organ and shows aggressive clinical features. Most commonly, angiosarcoma initially presents as a cutaneous lesion. Lung metastasis from scalp angiosarcoma can develop pneumothorax. We report a case of multiorgan involvement of an angiosarcoma, including the scalp, initially presenting with hydropneumothorax. Immunohistochemistry analysis of the cells obtained from the study confirmed the pleural invasion of the angiosarcoma.

Keywords: Angiosarcoma, hydropneumothorax, immunohistochemistry, scalp..


Article Information


Identifiers and Pagination:

Year: 2014
Volume: 8
First Page: 48
Last Page: 54
Publisher Id: TORMJ-8-48
DOI: 10.2174/1874306401408010048

Article History:

Received Date: 15/10/2014
Revision Received Date: 8/11/2014
Acceptance Date: 8/11/2014
Electronic publication date: 26 /12/2014
Collection year: 2014

Article Metrics:

CrossRef Citations:
0

Total Statistics:

Full-Text HTML Views: 806
Abstract HTML Views: 1012
PDF Downloads: 261
Total Views/Downloads: 2079

Unique Statistics:

Full-Text HTML Views: 518
Abstract HTML Views: 660
PDF Downloads: 175
Total Views/Downloads: 1353
Geographical View

© Chang et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.


* Address correspondence to this author at the Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Ewha Womans University, Anyangcheon-Ro 1071, Yangcheon-gu, Seoul, 158-710, South Korea; Tel : +82-2-2650-5686; Fax: +82-2-2655-2076; E-mail: hs1017@ewha.ac.kr




INTRODUCTION

Angiosarcoma is a rare aggressive malignancy that has a poor prognosis despite current intensive treatment [1Banks-Davis HJ. Haemmorrhagic angiosarcoma of upper jaw. Proc R Soc M Laryngol Sect 1923; 16: 49.-3Ito Y, Kojiro M, Nakashima T , et al. Pathomorphologic characteristics of 102 cases of thorotrast-relat hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 1988; 62: 1153-62.]. This tumor can involve multiple organs, including the pleura. Pneumothorax is known to develop from spontaneous rupture of cystic lung lesions in angiosarcoma [4Chen W, Shih CS, Wang YT, Tseng GC, Hsu WH. Angiosarcoma with pulmonary metastasis presenting with spontaneous bilateral pneumothorax in an elderly man. J Formos M Assoc 2006; 105: 238-41.]. In a case of pleural effusion of angiosarcoma, cytology is often negative pathologically under routine stains, and specific immunohistochemical stains can be confirmative [5Alexiou C, Clelland CA, Robinson D, Morgan WE. Primary angiosarcomas of the chest wall and pleura. Eur J Cardiothorac Surg 1998; 14: 523-6., 6Boucher LD, Swanson PE, Stanley MW , et al. Cytology of Angiosarcoma findings in fourteen fine-ne le aspiration biopsy specimens and one pleural fluid specimen. Am J Clin Pathol 2000; 114: 210-9.]. We report a case of angiosarcoma involving the heart, lungs, lymph nodes, scalp, and liver, with malignant pleural effusion.

CASE REPORT

An 83-year-old male visited a local clinic because of sudden chest pain, which developed 1 month prior and became aggravated 1 week previously. He was referred to our hospital for the problem of hydropneumothorax. There was no specific history or familial history of cancer, diabetes, or tuberculosis. He had a 25 pack-year of smoking history. On admission, he appeared acutely ill. His blood pressure was 110/70 mmHg, his pulse rate was 100 beats per minute, and his body temperature was 36.6°C. He showed a poor performance status with an Eastern Cooperative Oncology Group (ECOG) scale score of 3. A mass was palpated on the left supraclavicular area, and it was not tender and firm in consistency. There was a skin lesion of 6 mm in size that was not painful and that was violet and dome shaped in elevation on the left parietal lobe of the skull. Breathing sounds in the left lower lung field were decreased, and no crackles were heard. Other physical findings were negative. On the day of admission, his white blood cell count was 10,400/mm3 with 70% neutrophils and 25% lymphocytes, the hemoglobin level was 12.5 g/dL, and the platelet count was 269,000/mm3. Serum biochemical values were as follows: the blood urea nitrogen level was 23 mg/dL, the creatinine level was 1.6 mg/dL, the total protein level was 5.0 mg/dL, the albumin level was 2.6 mg/dL, and other values were within normal ranges. The levels of neuron-specific enolase, carcinoembryonic antigen, alpha fetoprotein, and CA 19-9 were 14.1 ng/mL, 3.6 ng/mL, 1.9 ng/mL, and 7.5 U/mL, respectively. Initial pleural fluid analysis showed a pH of 7.2, the white blood cell count was 6500/mm3 with 90% eosinophils, 7% lymphocytes, and 1% neutrophils, the total protein level was 3.3 mg/dL, the albumin level was 2.0 mg/dL, the lactic dehydrogenase level was 356 U/L, the adenosine-deaminase level was 29.4 U/L, and the carcinoembryonic antigen level was 6.1 ng/mL. Results for microbiology and cytology in the pleural fluid were negative. On the day of admission, chest radiography showed the finding of hydropneumothorax (Fig. 1). Chest computed tomography (CT) showed multiple tiny nodules and cystic lesions on both lungs, a large amount of pleural effusion with pneumothorax in the left lung, pericardial effusion, enlargement of multiple lymph nodes, and multiple hepatic masses (Fig. 2). Trans-thoracic echocardiography showed a mass with a diameter of 2.0 cm at the right atrioventricular orifice (Fig. 3). Because initial pleural fluid cytology was reported to be negative, excisional biopsy of the cervical lymph nodes was performed. Histopathology revealed that the lymph nodes were almost replaced by the tumor, which formed an anastomosing network of sinusoids lined by hyperchromatic nucleated endothelial cells (Fig. 4). Positron emission tomography-CT showed a standardized uptake value of 14.3 on fluorodeoxyglucose uptake at the left tonsil and also increased uptake at cervical lymph nodes, both lungs, and the liver (Fig. 5). A second thoracentesis revealed pleural metastasis of angiosarcoma under the stains of CD31, CD34, and von Willebrand factor for the atypical cell cluster of the pleural fluid (Fig. 6). Because of the involvement of angiosarcoma in the heart, lungs, pleura, multiple lymph nodes, skin, and liver, the patient was discharged after conservative treatment with consideration of age and current performance status.

Fig. (1)

Posterioranterior chest radiography and left decubitus film on admission show hydropneumothorax on the left side.



Fig. (2)

Computed tomography shows multiple tiny nodules and cystic lesions on both lungs, a large amount of left pleural effusion with pneumothorax, pericardial effusion, enlargement of multiple lymph nodes, and multiple hepatic masses.



Fig. (3)

Echocardiography shows a mass with a diameter of 2.0 cm at the right atrioventricular orifice.



Fig. (4)

Histological findings of cervical lymph nodes. (A) Lymph nodes are almost replaced by angiosarcoma, which forms an anastomosing network of sinusoids, lined by hyperchromatic, nucleated endothelial cells (hematoxylin and eosin (H&E) staining, × 40). (B) A distinct sinusoid pattern with malignant endothelial cells, some of which are scattered in the lumen of sinusoids, is seen (H&E stain, x 200).



Fig. (5)

Positron emission tomography-CT shows a standardized uptake value of 14.3 on fluorodeoxyglucose uptake at the left tonsil and also increased uptake at cervical lymph nodes, both lungs, and the liver.



Fig. (6)

Pathological findings of pleural fluid cytology. (A) H&E staining. (B-D) Immunohistochemical staining of an atypical cell cluster: (B) CD31, (C) CD34, and (D) von Willebrand factor (x 1000).



DISCUSSION

Angiosarcoma is a malignant cancer that rarely occurs and has a poor prognosis. Angiosarcoma occurs at a male predominance, and mostly affects elderly people, although it can occur at all ages. We reviewed 33 patients from 24 previous reports concerning angiosarcoma with pneumothorax that were based on a PubMed search since 1978. Among the 33 subjects, 21 cases were available for review; 16 subjects were male and 5 were female. The mean age was 68 years, and the most common computed tomography findings were multiple thin-walled cysts and nodules located in the subpleural area (Table 1). As a spontaneous pneumothorax in an aged person, the differential diagnosis was most commonly emphysema (91%), followed by isolated bulla or blebs (4%), mesothelioma (2%), and rare cases of subpleural fibrosis, congenital cystic adenomatoid malformation, tuberculous pleuritis, and angiosarcoma [7Jordan KG, Kwong JS, Flint J, Muller NL. Surgically treat pneumothorax radiologic and pathologic findings. Chest 1997; 111: 280-5.].

Table 1.

Cases of angiosarcoma with spontaneous pneumothorax reported since 1978.




Radiation therapy is a risk factor for angiosarcoma. In addition, vinyl chloride, thorium dioxide, arsenic, anabolic steroids, neurofibromatosis, Maffucci syndrome, and Klippel-Trenaunay syndrome are known to be risk factors [8Rouhani P, Fletcher CD, Devesa SS, Toro Jr. Cutaneous soft tissue sarcoma incidence patterns in the U, . an analysis f 1214 cases. Cancer 2008; 113: 616-27.-10Fayette J, Martin E, Piperno-Neumann S , et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site a retrospective study of 161 cases. Ann Oncol 2007; 18: 2030-6.].

There have been higher diagnostic yields over the years from the development of diagnostic technology, such as pathological technology [8Rouhani P, Fletcher CD, Devesa SS, Toro Jr. Cutaneous soft tissue sarcoma incidence patterns in the U, . an analysis f 1214 cases. Cancer 2008; 113: 616-27., 9Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma a report of 67 patients and a review of the literature. Cancer 1996; 77: 2400-6.]. Angiosarcoma as an angiogenic tumor can have a definite diagnosis by confirming vascular markers by immunochemistry. Endothelium-specific immune markers include CD31, CD34, and von Willebrand factor. Von Willebrand factor shows high specificity with relatively low sensitivity, while CD34 and CD31 show high specificity and sensitivity [6Boucher LD, Swanson PE, Stanley MW , et al. Cytology of Angiosarcoma findings in fourteen fine-ne le aspiration biopsy specimens and one pleural fluid specimen. Am J Clin Pathol 2000; 114: 210-9., 11De Young BR, Wick MR, Fitzgibbon JF, Sirgi KE, Swanson PE. CD31: an immunospecific marker for endothelial differentiation in human neoplasm. Appl Immunohistochem 1993; 1: 97-100.].

Angiosarcoma occurs at various locations, most commonly at the head and neck, breast, limbs and trunk [8Rouhani P, Fletcher CD, Devesa SS, Toro Jr. Cutaneous soft tissue sarcoma incidence patterns in the U, . an analysis f 1214 cases. Cancer 2008; 113: 616-27., 9Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma a report of 67 patients and a review of the literature. Cancer 1996; 77: 2400-6.]. With multiple organ involvement at the time of diagnosis, it can be difficult to conclude which area is the primary site. However, regarding pneumothorax, the scalp was the most common primary site of angiosarcoma [12Kitagawa M, Tanaka I, Takemura T, Matsubara O, Kasuga T. Angiosarcoma of the scalp report of two cases with fatal pulmonary complications and a review of Japanese autopsy registry data. Virch Arch A 1987; 412(1): 83-7.]. This was true in our case, as well as in literature reviews (Table 1). When angiosarcoma invades the lungs, pneumothorax or hemothorax results by forming nodular lesions or a cystic change [13Tateishi U, Hasegawa T, Kusumoto M , et al. Metastatic angiosarcoma of the lung spectrum of CT findings. Am J Roentgenol 2003; 180: 1671-4.]. Although there is no well-established treatment or prospective study results for angiosarcoma, radiation and surgery are recommended for localized lesions [3Ito Y, Kojiro M, Nakashima T , et al. Pathomorphologic characteristics of 102 cases of thorotrast-relat hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 1988; 62: 1153-62., 9Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma a report of 67 patients and a review of the literature. Cancer 1996; 77: 2400-6.]. When there is a high risk for the relapse of angiosarcoma, high-capacity radiation therapy above 50 Gy is recommended [9Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma a report of 67 patients and a review of the literature. Cancer 1996; 77: 2400-6.]. When metastatic, the primary treatment is cytotoxic chemotherapy, with the main drugs being doxorubicin, ifosfamide, and taxanes [14George S, Demetri GD. Systemic treatment of metastatic soft tissue sarcoma. http //wwwuptodatecom/contents/systemic-treatment-of-metastatic-soft-tissue-sarcoma 2014.]. When a patient has a poor status or is elderly, monotherapy with a taxane-class drug is recommended [15Young RJ, Brown NJ, Re MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol 2010; 11: 983-1.]. The 5-year survival rate for angiosarcoma is as low as 35%. A poor prognosis is predicted for factors such as the primary site of the liver, a performance above 2 on the ECOG scale, and the existence of metastatic lesions at the time of diagnosis [10Fayette J, Martin E, Piperno-Neumann S , et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site a retrospective study of 161 cases. Ann Oncol 2007; 18: 2030-6.].

CONCLUSION

Angiosarcoma should be considered in the differential diagnosis of advanced-aged people presenting with hydropneumothorax and cystic lung lesions. Scalp lesions should be searched in the presentation of pneumothorax in angiosarcoma. Immunohistochemistry provides an indicator for the diagnosis of malignant pleural effusion in angiosarcoma.

CONFLICT OF INTEREST

The authors confirm that this article content has no conflict of interest.

ACKNOWLEDGEMENTS

Thanks to Ms. Haesoo Chang for the support of English revision.

REFERENCES

[1] Banks-Davis HJ. Haemmorrhagic angiosarcoma of upper jaw. Proc R Soc M Laryngol Sect 1923; 16: 49.
[2] Bear PA, Moodie DS. Malignant primary cardiac tumors The Cleveland Clinic experience, 1956 to 1986. Chest 1987; 92: 860-2.
[3] Ito Y, Kojiro M, Nakashima T , et al. Pathomorphologic characteristics of 102 cases of thorotrast-relat hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 1988; 62: 1153-62.
[4] Chen W, Shih CS, Wang YT, Tseng GC, Hsu WH. Angiosarcoma with pulmonary metastasis presenting with spontaneous bilateral pneumothorax in an elderly man. J Formos M Assoc 2006; 105: 238-41.
[5] Alexiou C, Clelland CA, Robinson D, Morgan WE. Primary angiosarcomas of the chest wall and pleura. Eur J Cardiothorac Surg 1998; 14: 523-6.
[6] Boucher LD, Swanson PE, Stanley MW , et al. Cytology of Angiosarcoma findings in fourteen fine-ne le aspiration biopsy specimens and one pleural fluid specimen. Am J Clin Pathol 2000; 114: 210-9.
[7] Jordan KG, Kwong JS, Flint J, Muller NL. Surgically treat pneumothorax radiologic and pathologic findings. Chest 1997; 111: 280-5.
[8] Rouhani P, Fletcher CD, Devesa SS, Toro Jr. Cutaneous soft tissue sarcoma incidence patterns in the U, . an analysis f 1214 cases. Cancer 2008; 113: 616-27.
[9] Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma a report of 67 patients and a review of the literature. Cancer 1996; 77: 2400-6.
[10] Fayette J, Martin E, Piperno-Neumann S , et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site a retrospective study of 161 cases. Ann Oncol 2007; 18: 2030-6.
[11] De Young BR, Wick MR, Fitzgibbon JF, Sirgi KE, Swanson PE. CD31: an immunospecific marker for endothelial differentiation in human neoplasm. Appl Immunohistochem 1993; 1: 97-100.
[12] Kitagawa M, Tanaka I, Takemura T, Matsubara O, Kasuga T. Angiosarcoma of the scalp report of two cases with fatal pulmonary complications and a review of Japanese autopsy registry data. Virch Arch A 1987; 412(1): 83-7.
[13] Tateishi U, Hasegawa T, Kusumoto M , et al. Metastatic angiosarcoma of the lung spectrum of CT findings. Am J Roentgenol 2003; 180: 1671-4.
[14] George S, Demetri GD. Systemic treatment of metastatic soft tissue sarcoma. http //wwwuptodatecom/contents/systemic-treatment-of-metastatic-soft-tissue-sarcoma 2014.
[15] Young RJ, Brown NJ, Re MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol 2010; 11: 983-1.

Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)


Browse Contents



Webmaster Contact: info@benthamopen.net
Copyright © 2019 Bentham Open